Despite drug company’s and patients’ pleading, an FDA panel votes to rescind Avastin approval for breast cancer.
Advertisement
The Scientist
Most Recent
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
A new study suggests that new cancer treatments generally go on sale in the United States before they reach European markets
Two sisters—Kate, a developmental biologist, and Helen, a high-end fashion designer—team up to develop a couture collection inspired by the first 1,000 hours of embryonic life. Dubbed Primitive Streak—after the early embryonic process that results in
Is DNA damage an inevitable consequence of epigenetic reprogramming?
Postdoc forced to leave position after questioning the reproducibility of advisor's data
Two sisters -- a developmental biologist and high-end fashion designer -- team up to develop a couture collection inspired by the first 1,000 hours of embryonic life
Skeleton Keys
| May 14, 2011
There are a surprising number of unknowns about how our limbs come to be symmetrical.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
